| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 156.99B | 138.28B | 116.44B | 107.02B | 74.49B | 51.55B |
| Gross Profit | 68.85B | 60.53B | 50.33B | 45.14B | 32.67B | 20.60B |
| EBITDA | 19.23B | 17.45B | 14.41B | 12.18B | 8.48B | 2.71B |
| Net Income | 10.95B | 10.59B | 8.86B | 7.33B | 5.78B | 1.10B |
Balance Sheet | ||||||
| Total Assets | 123.67B | 110.91B | 92.68B | 80.70B | 67.34B | 55.61B |
| Cash, Cash Equivalents and Short-Term Investments | 35.37B | 29.48B | 23.55B | 16.91B | 17.92B | 13.27B |
| Total Debt | 16.74B | 11.21B | 8.80B | 5.14B | 2.23B | 2.69B |
| Total Liabilities | 46.98B | 41.48B | 31.77B | 27.60B | 21.61B | 15.96B |
| Stockholders Equity | 76.46B | 69.20B | 60.70B | 52.92B | 45.61B | 39.65B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 7.18B | 5.92B | -483.00M | 6.55B | 3.84B |
| Operating Cash Flow | 0.00 | 12.98B | 12.49B | 2.99B | 7.43B | 4.54B |
| Investing Cash Flow | 0.00 | -5.76B | -7.37B | -4.46B | -2.29B | -1.07B |
| Financing Cash Flow | 0.00 | -2.61B | 764.00M | -480.00M | -1.96B | -1.28B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥8.98B | 16.36 | ― | 3.96% | 7.77% | 247.26% | |
75 Outperform | ¥3.96B | 8.35 | ― | 4.78% | -11.24% | -48.52% | |
63 Neutral | ¥1.49T | 42.60 | 5.92% | 1.93% | 7.64% | 22.13% | |
62 Neutral | ¥268.25B | 21.92 | 15.93% | 0.72% | 20.06% | 17.89% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
56 Neutral | ¥26.99B | 14.57 | ― | 1.85% | 4.17% | -20.08% | |
49 Neutral | ¥47.06B | 11.29 | ― | 3.94% | 0.74% | 41.25% |